Spec. MD. Nazmiye Deniz Arslan

Education & Specialization

• 2008: Ondokuz Mayıs University Faculty of Medicine – Medical Degree

• 2014: Şişli Hamidiye Etfal Training and Research Hospital – Radiation Oncology Specialization

• 2021: Health Sciences University – PhD Program in Molecular Oncology

Experience

• 2008–2009: Hopa Central Health Center

• 2009–2014: Bezmialem Vakıf Gureba Training and Research Hospital

• 2010–2019: Şişli Hamidiye Etfal Training and Research Hospital

• 2017: University of Maryland, Maryland Proton Center

• 2019–2022: Istanbul Yedikule Chest Diseases and Chest Surgery Training and Research Hospital

• Kızılkaya ve ark., A Comparison of Magnetic Resonance and Computed Tomography Imaging  Based Target-Volume Definition and Interfraction Variations of Treatment Planning Parameters (D90 HR-CTV, D2cc for OARs) During Image Guided Adaptive Brachytherapy for Cervical Cancer. UHOD Number: Volume: 29 Year: 2019 .doi: 10.4999/uhod.
• Dağ ve ark., Comparison of VMAT, Field in Field, Inverse IMRT, and Helical Tomotherapy Planning in Bilateral Synchronous Breast Cancer: A Case Study. Turk J Oncol 2019;35(1):00–00 doi: 10.5505/tjo.2019.632.
• Dağ ve ark., Comparison of the prognostic value of F-18 FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy, Brachytherapy. 2018 Dec 26. pii: S1538-4721(18)30066-7.    doi: 10.1016/j.brachy.2018.11.005
• Hasan Morcalı, Metin Figen, Ayşe Okumuş, Nazmiye Deniz Arslan and Hazım Orhan Kızılkaya,Outcomes of neoadjuvant chemoradiotherapy in patients with locally advanced      rectal cancer a single institution experience, Journal of Human Rhythm 2015:1(1):37-41
• Arslan ND, Kızılkaya HO, Kutluhan Doğan A, Factors Affecting “Organs at Risk” Doses in 3 Dimensional Brachytherapy (3D BRT) of Cervical and Endometrium Cancers, IJESEN, 2020:  6 ( 3), 145 – 151